Incidence and risk factors of nephritis in childhood Henoch-Schönlein purpura

被引:0
|
作者
Yanrismet, Yaulia [1 ]
Hidayati, Eka Laksmi [1 ]
Munasir, Zakiudin [1 ]
Yuliarti, Klara [1 ]
Fahriyani, Afifa [1 ]
机构
[1] Univ Indonesia, Dr Cipto Mangunkusumo Natl Hosp, Dept Pediat Hlth, Med Sch, Jl Diponegoro 71, Jakarta 10430, Indonesia
关键词
Henoch-Schonlein purpura; nephritis; childhood; risk factors; HENOCH-SCHONLEIN PURPURA; RENAL INVOLVEMENT; SIGNIFICANT PROTEINURIA; MULTIVARIATE-ANALYSIS; PREDICTIVE FACTORS; FOLLOW-UP; CHILDREN; THROMBOPOIETIN; PATHOGENESIS; PREDNISONE;
D O I
10.14238/pi63.4.2023.304-14
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Henoch-Schonlein Purpura (HSP) is the most common systemic vasculitis disease in children. It is characterized by involvement of the skin, joints, gastrointestinal tract, and kidney. Kidney manifestations may progress to severe nephritis, even lead to end-stage kidney disease.Objective To identify the incidence and risk factors of nephritis in childhood HSP.Methods A retrospective cohort study was performed to evaluate clinical, demographic, laboratory, and therapeutic parameters of HSP patients aged 0-18 years between 2011-2019 at Dr. Cipto Mangunkusumo Hospital, Jakarta. Diagnoses of HSP were made according to the 2008 EULAR/PRES/PR INTO criteria. We followed subjects' medical records for at least 3 months after disease onset to observe incidence and risk factors of HenochSchonlein nephritis (HSN).Results There were 112 HSP patients (aged 2-17 years) included in this study. HSN was found in 40 out of 112 patients (35.7%). Nephritis developed within the first 4 weeks for a majority of cases. Multivariate analysis showed that persistent purpura (OR 3.306; 95%CI 1.315 to 8.315; P=0.011) and acute phase leukocytosis (OR 2.585; 95%CI 1.047 to 6.385; P=0.039) were significantly associated risk factors for HSN. We found that corticosteroid use did not reduce the risk of HSN. The accumulation of several risk factors was associated with the likelihood of developing HSN. Conclusion Persistent purpura and acute phase leukocytosis are independent risk factors for HSN. Therefore, blood tests are needed to estimate the risk of HSN. Early corticosteroid therapy do not reduce theriskofkidneyimpairment.
引用
收藏
页码:304 / 314
页数:11
相关论文
共 50 条
  • [1] Henoch-Schönlein purpura nephritis: an update
    Jean-Claude Davin
    Jan Weening
    [J]. European Journal of Pediatrics, 2001, 160 : 689 - 695
  • [2] Pathogenesis of Henoch-Schönlein purpura nephritis
    Keith K. Lau
    Hitoshi Suzuki
    Jan Novak
    Robert J. Wyatt
    [J]. Pediatric Nephrology, 2010, 25 : 19 - 26
  • [3] Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management
    Jun-Yi Chen
    Jian-Hua Mao
    [J]. World Journal of Pediatrics, 2015, 11 : 29 - 34
  • [4] Histological prognostic factors in children with Henoch-Schönlein purpura nephritis
    Jean-Daniel Delbet
    Guillaume Geslain
    Martin Auger
    Julien Hogan
    Rémi Salomon
    Michel Peuchmaur
    Georges Deschênes
    David Buob
    Cyrielle Parmentier
    Tim Ulinski
    [J]. Pediatric Nephrology, 2020, 35 : 313 - 320
  • [5] Erratum to: Pathogenesis of Henoch-Schönlein purpura nephritis
    Keith K. Lau
    Hitoshi Suzuki
    Jan Novak
    Robert J. Wyatt
    [J]. Pediatric Nephrology, 2010, 25 (1) : 179 - 179
  • [6] Polymorphism of the ACE gene in Henoch-Schönlein purpura nephritis
    J. Dudley
    E. Afifi
    A. Gardner
    E. J. Tizard
    M. E. McGraw
    [J]. Pediatric Nephrology, 2000, 14 : 218 - 220
  • [7] Muscle involvement in a patient with Henoch-Schönlein purpura nephritis
    Toru Watanabe
    Yuki Abe
    [J]. Pediatric Nephrology, 2004, 19 : 227 - 228
  • [8] RISK FACTORS IN HENOCH-SCH.NLEIN PURPURA NEPHRITIS
    Monov, S.
    Todorov, T.
    Monova, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1601 - 1602
  • [9] Henoch-Schönlein purpura.
    Gedalia A.
    [J]. Current Rheumatology Reports, 2004, 6 (3) : 195 - 202
  • [10] Encephalopathy in Henoch-Schönlein purpura
    Huijun Shen
    Jianhua Mao
    Qiang Shu
    Lizhong Du
    [J]. Indian Pediatrics, 2017, 54 : 675 - 677